Search results
Results from the WOW.Com Content Network
The liver span is a measurement performed during physical examination ... Normal liver span is 6–12 cm (2.4–4.7 in), but varies with age, height, and weight ...
On abdominal ultrasonography, the liver can be measured by the maximum dimension on a sagittal plane view through the midclavicular line, which is normally up to 18 cm in adults. [2] It is also possible to measure the cranio-caudal dimension, which is normally up to 15 cm in adults. [2]
Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis, chronic liver failure or chronic hepatic failure and end-stage liver disease, is an acute condition of the liver in which the normal functioning tissue, or parenchyma, is replaced with scar tissue and regenerative nodules as a result of chronic liver disease.
The liver scratch test is a type of auscultatory percussion that uses the difference in sound transmission between solid and hollow organs in the abdominal cavity in order to locate the inferior edge of the liver.
About 20,000 protein coding genes are expressed in human cells and 60% of these genes are expressed in a normal, adult liver. [ 34 ] [ 35 ] Over 400 genes are more specifically expressed in the liver, with some 150 genes highly specific for liver tissue.
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
Liver failure is the inability of the liver to perform its normal synthetic and metabolic functions as part of normal physiology. Two forms are recognised, acute and chronic (cirrhosis). [ 1 ] Recently, a third form of liver failure known as acute-on-chronic liver failure ( ACLF ) is increasingly being recognized.
The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease.It was initially developed to predict mortality within three months of surgery in patients who had undergone a transjugular intrahepatic portosystemic shunt (TIPS) procedure, [1] and was subsequently found to be useful in determining prognosis and prioritizing for receipt of ...